Skip to content

Diagnosis of Clostridioides difficile infection using CRISPR/Cas system

Diagnosis of Clostridioides difficile infection using CRISPR/Cas system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111676
Enrollment
Unknown
Registered
2025-11-04
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridioides difficile infection

Interventions

Gold Standard:Quantitative Real-time PCR
Index test:Nucleic acid detection based on CRISPR/Cas system

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients aged 18 years or older; 2. Gender: both male and female; 3. Have received antibiotic therapy or chemotherapy within the past 60 days, developed diarrhea after 48 hours of hospitalization, and experienced three or more episodes of diarrhea within 24 hours; 4. Unformed stools (Bristol stool types 5–7).

Exclusion criteria

Exclusion criteria: 1. Patients under 18 years of age; 2. Patients with chronic diarrhea; 3. Those who have used laxatives within 72 hours before screening; 4. Those with a history of unclean food consumption; 5. Other diarrhea with clear causes, such as lactose intolerance; 6. Patients who have already participated in this study and provided a sample once.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Positive Predictive Value;Negative Predictive Value;

Countries

China

Contacts

Public ContactChen Yijian

Institute of Antibiotics, Huashan Hospital, Fudan University

chenyijian@fudan.edu.cn+86 189 6438 5725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026